Search Results - Ian M. Catlett

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cover Image

    Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial by Ian M. Catlett, Lu Gao, Yanhua Hu, Subhashis Banerjee, James G. Krueger

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2 by Ian M. Catlett, Urvi Aras, Lars Hansen, Yali Liu, Di Bei, Ihab G. Girgis, Bindu Murthy

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: